Levetiracetam for Benign Rolandic Epilepsy

Completed · Phase 4

Conditions studied: Epilepsy

In brief

This study is designed to test if the language problems commonly seen in children with benign rolandic epilepsy would improve by switching anticonvulsants to levetiracetam.

Key facts

Study ID

NCT00181116

Run by

Johns Hopkins University

People needed

6

Starts

2005-03-01

Expected to finish

2006-09-01

Last updated by the study team

2009-03-27

Who can join

Age: 6 and older, up to 12. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Ages 6-12
• Benign rolandic epilepsy
• Language difficulties as reported by parents or teachers
• On another anticonvulsant other than levetiracetam

You may not qualify if…

• Prior use of levetiracetam
• On 2 or more anticonvulsants
• Language problems prior to epilepsy
• Another seizure disorder
• Status epilepticus within the past 6 months
• Significant psychiatric disease
• Progressive neurologic disease

Where it is running

• Johns Hopkins Hospital — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.